• Hims & Hers Health stock is at significant support. What’s pressuring HIMS?What HappenedLast Thursday, Hims & Hers Health announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill with the same active ingredient as Novo Nordisk’s Wegovy, at a special introductory offer starting at just $49 for the first month.Novo Nordisk said that Hims & Hers will unlawfully mass-market an unapproved, inauthentic, and untested knockoff semaglutide pill.On Friday ...